Prevalence and genotype distribution of HPV6/11/16/18 infections among 180,276 outpatient females from a Women’s and Children’s Central Hospital, 2015–2021, Chengdu, China

Abstract The aims of this study on human papilloma virus (HPV) 6/11/16/18 infection among females in Chengdu were to provide more targeted strategies for the prevention and treatment of cervical cancer and genital warts. In this study, the infection status of 20 genotypes was analysed by gene chip t...

Full description

Bibliographic Details
Main Authors: Xiaoqing Wei, Junying Zhang, Youwen Mei, Qianling Dai, Xiaoli Yang, Xuemei Wang
Format: Article
Language:English
Published: Nature Portfolio 2023-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-48222-1
_version_ 1797388365273759744
author Xiaoqing Wei
Junying Zhang
Youwen Mei
Qianling Dai
Xiaoli Yang
Xuemei Wang
author_facet Xiaoqing Wei
Junying Zhang
Youwen Mei
Qianling Dai
Xiaoli Yang
Xuemei Wang
author_sort Xiaoqing Wei
collection DOAJ
description Abstract The aims of this study on human papilloma virus (HPV) 6/11/16/18 infection among females in Chengdu were to provide more targeted strategies for the prevention and treatment of cervical cancer and genital warts. In this study, the infection status of 20 genotypes was analysed by gene chip technology. The prevalence rates of HPV-6, -11, -16, and -18 infection among 180,276 cases were 0.94%, 0.57%, 3.22%, and 1.28%, respectively. The prevalence of HPV 6/11/16/18 showed a bimodal U-shaped curve with age; the first and second peak occurred among females < 20 and ≥ 60 years old, respectively. As the multiplicity of infections involving HPV6/11/16/18 increases, the infection rate decreases. The ratios of HPV16 single infection showed a yearly increase. The top five genotypes with HPV-16, -18, -6, and -11 in coinfection were HPV52/58/53/51/33, HPV 52/16/53/58/51, HPV52/16/58/51/53 and HPV16/52/58/59/18, respectively, HPV16/18/6/11 were mainly coinfected with HR-HPV. In sum, among the five vaccines available, nonavalent vaccine is more suitable for Chengdu females. For young females prioritizing vaccination is essential in the current context, while HPV screening remains an effective approach for older females. Additionally, in patients with genital warts, it is necessary to assess the presence of high-risk HPV infection and manage it appropriately in patients with genital warts.
first_indexed 2024-03-08T22:38:43Z
format Article
id doaj.art-bdb75bcd39494b659f87fdf5c6d5a098
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-08T22:38:43Z
publishDate 2023-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-bdb75bcd39494b659f87fdf5c6d5a0982023-12-17T12:17:52ZengNature PortfolioScientific Reports2045-23222023-12-0113111210.1038/s41598-023-48222-1Prevalence and genotype distribution of HPV6/11/16/18 infections among 180,276 outpatient females from a Women’s and Children’s Central Hospital, 2015–2021, Chengdu, ChinaXiaoqing Wei0Junying Zhang1Youwen Mei2Qianling Dai3Xiaoli Yang4Xuemei Wang5Department of Cervical Disease and Cervical Cancer Prevention and Treatment, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of ChinaClinical Laboratory Department, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of ChinaDepartment of Assisted reproduction department, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of ChinaDepartment of Cervical Disease and Cervical Cancer Prevention and Treatment, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of ChinaDepartment of Cervical Disease and Cervical Cancer Prevention and Treatment, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of ChinaClinical Laboratory Department, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of ChinaAbstract The aims of this study on human papilloma virus (HPV) 6/11/16/18 infection among females in Chengdu were to provide more targeted strategies for the prevention and treatment of cervical cancer and genital warts. In this study, the infection status of 20 genotypes was analysed by gene chip technology. The prevalence rates of HPV-6, -11, -16, and -18 infection among 180,276 cases were 0.94%, 0.57%, 3.22%, and 1.28%, respectively. The prevalence of HPV 6/11/16/18 showed a bimodal U-shaped curve with age; the first and second peak occurred among females < 20 and ≥ 60 years old, respectively. As the multiplicity of infections involving HPV6/11/16/18 increases, the infection rate decreases. The ratios of HPV16 single infection showed a yearly increase. The top five genotypes with HPV-16, -18, -6, and -11 in coinfection were HPV52/58/53/51/33, HPV 52/16/53/58/51, HPV52/16/58/51/53 and HPV16/52/58/59/18, respectively, HPV16/18/6/11 were mainly coinfected with HR-HPV. In sum, among the five vaccines available, nonavalent vaccine is more suitable for Chengdu females. For young females prioritizing vaccination is essential in the current context, while HPV screening remains an effective approach for older females. Additionally, in patients with genital warts, it is necessary to assess the presence of high-risk HPV infection and manage it appropriately in patients with genital warts.https://doi.org/10.1038/s41598-023-48222-1
spellingShingle Xiaoqing Wei
Junying Zhang
Youwen Mei
Qianling Dai
Xiaoli Yang
Xuemei Wang
Prevalence and genotype distribution of HPV6/11/16/18 infections among 180,276 outpatient females from a Women’s and Children’s Central Hospital, 2015–2021, Chengdu, China
Scientific Reports
title Prevalence and genotype distribution of HPV6/11/16/18 infections among 180,276 outpatient females from a Women’s and Children’s Central Hospital, 2015–2021, Chengdu, China
title_full Prevalence and genotype distribution of HPV6/11/16/18 infections among 180,276 outpatient females from a Women’s and Children’s Central Hospital, 2015–2021, Chengdu, China
title_fullStr Prevalence and genotype distribution of HPV6/11/16/18 infections among 180,276 outpatient females from a Women’s and Children’s Central Hospital, 2015–2021, Chengdu, China
title_full_unstemmed Prevalence and genotype distribution of HPV6/11/16/18 infections among 180,276 outpatient females from a Women’s and Children’s Central Hospital, 2015–2021, Chengdu, China
title_short Prevalence and genotype distribution of HPV6/11/16/18 infections among 180,276 outpatient females from a Women’s and Children’s Central Hospital, 2015–2021, Chengdu, China
title_sort prevalence and genotype distribution of hpv6 11 16 18 infections among 180 276 outpatient females from a women s and children s central hospital 2015 2021 chengdu china
url https://doi.org/10.1038/s41598-023-48222-1
work_keys_str_mv AT xiaoqingwei prevalenceandgenotypedistributionofhpv6111618infectionsamong180276outpatientfemalesfromawomensandchildrenscentralhospital20152021chengduchina
AT junyingzhang prevalenceandgenotypedistributionofhpv6111618infectionsamong180276outpatientfemalesfromawomensandchildrenscentralhospital20152021chengduchina
AT youwenmei prevalenceandgenotypedistributionofhpv6111618infectionsamong180276outpatientfemalesfromawomensandchildrenscentralhospital20152021chengduchina
AT qianlingdai prevalenceandgenotypedistributionofhpv6111618infectionsamong180276outpatientfemalesfromawomensandchildrenscentralhospital20152021chengduchina
AT xiaoliyang prevalenceandgenotypedistributionofhpv6111618infectionsamong180276outpatientfemalesfromawomensandchildrenscentralhospital20152021chengduchina
AT xuemeiwang prevalenceandgenotypedistributionofhpv6111618infectionsamong180276outpatientfemalesfromawomensandchildrenscentralhospital20152021chengduchina